Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Inhibiting systemic autophagy during interleukin 2 immunotherapy promotes long-term tumor regression.

Inhibiting systemic autophagy during interleukin 2 immunotherapy promotes long-term tumor regression. Cancer Res. 2012 Jun 01; 72(11):2791-801.

View in: PubMed

© 2021 President and Fellows of Harvard College
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.